Mythology of Parkinson’s disease: from levodopa phobia to dopamine agonist phobia
Any common disease (including Parkinson’s disease) is inevitably overgrown with myths. As a result, not scientifically grounded approaches based on the principles of evidence-based medicine, but irrational ideas, especially often of a pharmacophobic nature, begin to dominate in primary clinical prac...
Main Authors: | O. S. Levin, A. Sh. Chimagomedova, O. V. Yakovleva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2020-12-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/5917 |
Similar Items
-
Levodopa versus levodopa sparing in early parkinson’s disease: can we meet halfway?
by: Mayela Rodríguez-Violante, et al.
Published: (2024-07-01) -
Levodopa enhances reward learning but impairs reversal learning in Parkinson’s disease patients
by: Ahmed A. Moustafa
Published: (2011-01-01) -
Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01) -
Adverse effects of medications used to treat motor symptoms of Parkinson′s disease: A narrative review
by: Bhushan Mishal, et al.
Published: (2023-01-01) -
An assessment of Parkinson’s disease medication treatment patterns in the Medicaid population
by: Michael Johnsrud, et al.
Published: (2021-01-01)